Literature DB >> 2576939

Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.

M Okazaki, A Miya, N Tanaka, T Miki, M Yamamoto, K Motomura, A Miyauchi, T Mori, S Takai.   

Abstract

The multiple endocrine neoplasia type 2A (MEN 2A) gene has been mapped to the centromeric region of chromosome 10 by linkage analysis. We examined 36 medullary thyroid carcinomas (MTCs) (16 hereditary and 20 sporadic) and ten pheochromocytomas (eight hereditary and two sporadic) to detect loss of alleles on chromosome 10 using seven polymorphic DNA markers mapped to this chromosome. Of 20 informative cases, only one (5%) sporadic MTC showed loss of heterozygosity at the locus RBP3. Allele loss at the RBP3 locus was not found in pheochromocytomas from six heterozygotes. All tumors retained constitutional heterozygosity at six other loci on chromosome 10 (D10S17, D10S34, D10S24 on the short arm, D10S15 in the pericentromeric region, D10S20, and D10S4 on the long arm). Our findings suggest that the second hit for tumorigenesis in MEN 2A may not be loss of function of the normal allele at the homologous locus on the other copy of chromosome 10. Mutated ras oncogene was found only in one of 18 MTCs at the codon 61 of H-ras.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576939

Source DB:  PubMed          Journal:  Henry Ford Hosp Med J        ISSN: 0018-0416


  7 in total

Review 1.  Thyroid C-Cell Biology and Oncogenic Transformation.

Authors:  Gilbert J Cote; Elizabeth G Grubbs; Marie-Claude Hofmann
Journal:  Recent Results Cancer Res       Date:  2015

Review 2.  Biology of tumors of the peripheral nervous system.

Authors:  G M Brodeur; J F Moley
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

3.  Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon.

Authors:  A Boichard; L Croux; A Al Ghuzlan; S Broutin; C Dupuy; S Leboulleux; M Schlumberger; J M Bidart; L Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2012-08-03       Impact factor: 5.958

4.  Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers.

Authors:  Taccaliti A; Silvetti F; Palmonella G; Boscaro M
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

5.  Loss of heterozygosity on chromosome 1p in thyroid adenoma and medullary carcinoma, but not in papillary carcinoma.

Authors:  K Kubo; K Yoshimoto; Y Yokogoshi; M Tsuyuguchi; S Saito
Journal:  Jpn J Cancer Res       Date:  1991-10

6.  Deletion mapping of chromosome 1p and 22q in pheochromocytoma.

Authors:  E Shin; S Fujita; K Takami; H Kurahashi; Y Kurita; T Kobayashi; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1993-04

7.  Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma.

Authors:  I Yana; T Nakamura; E Shin; K Karakawa; H Kurahashi; Y Kurita; T Kobayashi; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1992-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.